Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00103974
Recruitment Status : Completed
First Posted : February 18, 2005
Last Update Posted : April 7, 2008
Information provided by:
Bayhill Therapeutics